The study also reported a 40% incidence of dysferlinopathies, with LGMD2 being the most common subgroup and a male-to-female ratio of 1.5:1 [3]. This evidence concerns the gene CAPN3 and neuromuscular disease caused by qualitative or quantitative defects of dysferlin.